AstraZeneca(AZN) - 2022 Q4 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q4 2022 Earnings Conference Call February 9, 2023 6:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director & Chief Executive Officer Aradhana Sarin - Executive Director & Chief Financial Officer David Fredrickson - Executive Vice President of Oncology Business Unit Susan Galbraith - Executive Vice President of Oncology Research & Development Ruud Dobber - Executive Vice President of BioPharmaceuticals Business Unit Menelas Pang ...